(Q33328092)

English

Cisplatin, doxorubicin and etoposide (PAV) in advanced gastric carcinoma: the SAKK experience. Swiss Group for Clinical Cancer Research (SAKK).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Cisplatin, doxorubicin and etoposide (PAV) in advanced gastric carcinoma: the SAKK experience. Swiss Group for Clinical Cancer Research (SAKK). (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Roth AD

1

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Herrmann R

2

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Morant R

3

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Borner MM

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Honegger HP

5

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Obrist R

6

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Bacchi M

7

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Lange J

8

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Alberto P

9

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Castiglione M

10

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

publication date

1 December 1998

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

European Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

34

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

2126-2128

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Grou

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900262-7

7 January 2021

based on heuristic

inferred from DOI database lookup

FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900262-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluorouracil, doxorubicin, and mitomycin combination versus PELF chemotherapy in advanced gastric cancer: a prospective randomized trial of the Italian Oncology Group for Clinical Research

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900262-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900262-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900262-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II Trial of Etoposide (V), Adriamycin (A), and Cisplatinum (P) in Patients with Metastatic Gastric Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900262-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Etoposide, doxorubicin, and cisplatin chemotherapy for advanced gastric adenocarcinoma: results of a phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900262-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Early versus late alternating chemotherapy in small-cell lung cancer. Swiss Group for Clinical Cancer Research (SAKK).

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900262-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimal two-stage designs for phase II clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900262-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900262-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin, glutathione, and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900262-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Docetaxel (Taxotere) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900262-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy for advanced gastric cancer: where do we stand?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900262-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0959-8049(98)00262-7

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33328092&oldid=1981486010"